• Home
  • Study Details
By physician referral or invitation only

Benzodiazepine Use and Deprescribing Study

We will study how Medicare health insurance claims can capture medication deprescribing. Medication deprescribing is a way to reduce risk of serious health problems by carefully and systematically stopping use of medications where the harms outweigh the benefits. To do so, the healthcare provider (e.g., doctor, pharmacist) and patient review all of the patient's medications, prioritize medications for stopping, and gradually (and with careful monitoring) reduce or stop using those medications. Insurance claims capture prescription drug information on a large number of older adults over time and therefore, are ideal for studying medication use. However, they do not describe why a patient stopped using a medication, and there are many reasons a patient may stop (e.g., side effects, costs). The goal of our study is to see how well we can capture deprescribing using insurance claims data.

Age & Gender

  • 65 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Jennifer Lund
Epidemiology

Study Type

Clinical or Medical
Observational

Study Topics

Aging
Healthy Volunteer or General Population

IRB Number

21-0408

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research